ALung Releases its 2014 Year in Review Summary

23 December 2014 Press Release

Pittsburgh, PA (December 23, 2014) – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, today released its first Year in Review Summary, covering 2014. ALung experienced significant year over year growth in 2014, with utilization of its Hemolung Respiratory Assist System (RAS) (read more)

First US Patient Supported with the Hemolung RAS

1 July 2014 Press Release

Pittsburgh, PA (July 2, 2014) – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, issued the following statement today from ALung Chairman and CEO Peter DeComo: “Yesterday, the Associated Press reported on the first ever use of our Hemolung RAS in the (read more)

Hemolung RAS Recipient of Gold Award at Medical Design Excellence Awards

12 June 2014 Press Release

World’s First and only Fully-Integrated Respiratory Dialysis® System Obtains Highest Honor in Critical-Care and Emergency Medicine Product Category Pittsburgh, PA (June 12, 2014) – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today that the Hemolung Respiratory Assist System (RAS) has won (read more)

ALung Technologies Raises $10 Million

19 May 2014 Press Release

Pittsburgh, PA (May 19, 2014) – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for supporting patients with acute respiratory failure, today announced that it has closed on approximately $10 million in new financing from both new and existing investors. The proceeds will primarily support ongoing commercialization of ALung’s (read more)

ALung Technologies Named Tech 50 Life Science Company of the Year

11 October 2013 Press Release

Pittsburgh Technology Council Awards ALung Technologies based on Strong Growth, Financial Stability, and Product Advancements Pittsburgh, PA (October 11, 2013) – ALung Technologies, Inc., a leading developer of innovative respiratory assist devices, announced today that it has been named “Life Science Company of the Year” by the Pittsburgh Technology Council’s Tech 50 Awards Program. Tech 50 winners were announced (read more)

ALung Showcases the Hemolung RAS at ESICM in Paris

2 October 2013 Press Release

New European Hires made to Support Launch PITTSBURGH PA, (October 2,2013) – ALung Technologies, Inc., a leading developer of innovative respiratory assist devices, today announced it will showcase the Hemolung RAS next week at the 2013 Annual Congress of the European Society of Intensive Care Medicine (ESICM) in Paris. This announcement follows ALung’s recent hiring of its (read more)

ALung Launches Hemolung RAS in France at SFAR

12 September 2013 Press Release

Jean-Michel Dutois Hired As French Country Manager Pittsburgh, PA (September 12, 2013) – ALung Technologies, Inc., a leading developer of innovative respiratory assist devices, today announced its launch of the Hemolung Respiratory Assist System (RAS) in France. ALung will showcase the Hemolung RAS next week at the 2013 National Congress of the French Society of (read more)

ALung présente le système Hemolung RAS en France à l’occasion du congrès national de la SFAR

12 September 2013 Press Release

Jean-Michel Dutois désigné comme directeur général pour la France Pittsburgh, Pennsylvanie (12 septembre 2013) – ALung Technologies, Inc., une des principales entreprises de développement d’appareils d’assistance respiratoire innovants, a annoncé aujourd’hui le lancement en France de son système d’assistance respiratoire Hemolung Respiratory Assist System (RAS). ALung le présentera la semaine prochaine, lors du Congrès National (read more)

ALung Technologies Raises $15.8 Million in Series B-1 Financing

11 September 2013 Press Release

Pittsburgh, PA (September 11, 2013) – ALung Technologies, Inc., a leading developer of innovative respiratory assist devices, today announced that it has closed a $15.8 million Series B-1 financing round. Allos Ventures led the financing, with West Capital Partners, Birchmere Ventures, BlueTree Capital Group, PLSG Accelerator Fund, Smithfield Trust Company, and several additional private investors also participating in (read more)

ALung to Pursue SFDA Approval of Hemolung RAS in China

21 May 2013 Press Release

Agreement Signed with Curative Medical to Initiate Clinical Trial. PITTSBURGH, PA (May 21, 2013) – ALung Technologies, Inc., a leading developer of innovative respiratory assist devices, today announced that it has signed an agreement with Curative Medical, Inc. to pursue China’s State Food and Drug Administration (“SFDA”) approval for the Hemolung Respiratory Assist System (RAS). Under the terms (read more)